Ganaxolone
Back to searchMolecule Structure
Scientific Name
Ganaxolone
Description of the Drug
Ganaxolone is a neuroactive steroid GABA-A receptor modulator used for the treatment of seizures associated with CDKL5 deficiency disorder (CDD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05087
http://www.drugbank.ca/drugs/DB05087
Brand Name(s)
Ztalmy
Company Owner(s)
Marinus Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL144522 | |
| PharmGKB | PA166278301 | |
| DrugBank | DB05087 | |
| PubChem: Thomson Pharma | 14875327 | 14802011 |
| PubChem | 6918305 | |
| LINCS | LSM-45679 | |
| Nikkaji | J805.191G | |
| BindingDB | 50369240 | |
| EPA CompTox Dashboard | DTXSID6046503 | |
| PubChem: Drugs of the Future | 12014974 | |
| ChEBI | 177658 | |
| ZINC | ZINC000003824281 |
